Water fluctuations mediate lock-and-key fit
With the help of computer simulation, researchers have been
able to calculate the movements and forces between
water molecules (small, red-and-white dipoles), a ligand (shown in green),
and the protein molecule's water-repellant hollow pocket.
Without water, life as we know, it would not exist. Nearly every biological binding process that takes place within a cell requires the presence of an aqueous environment. Here, tiny molecules called ligands fit like "keys" into their matching "locks" - docking sites on larger protein molecules. This in turn activates signals or leads to the production of some other substance by the cell. But what was previously unclear, was the part water plays in all this. Is water merely a passive transport medium or does it perform other, more active jobs as well? Now, HZB's own Prof. Dr. Joachim Dzubiella and a team of physicists have looked for answers to this question using a computer simulated model system. In the process, they discovered that water is capable of actively influencing the docking speed of the ligand through subtle interactions with other molecules' unique geometry and surface topography. Their findings could become important in drug delivery.
Together with his colleagues at the TU Munich, UC San Diego, and the University of Utah, Dzubiella has modeled a small ligand molecule docking to a protein binding pocket and then calculated the various movements and forces involved in this process. In their work, the researchers went on the assumption that the protein pocket's surface was hydrophobic. When tiny water molecules tried to enter the protein pocket, they were repelled by the hydrophobicity of its surface. This in turn produced a small wave, which swept up the ligands in the area. "This is exciting news”, says Dzubiella, “because it seems that proteins can use their local geometry and polarity to create well-controlled hydrodynamic fluctuations which accelerate or decelerate approaching ligands.” These results add not only to our fundamental understanding of biological binding processes but will be helpful for the design of biomolecules and drugs in biomedical and biomaterial applications.
The results have been published in the renowned PNAS.
arö
https://www.helmholtz-berlin.de/pubbin/news_seite?nid=13651;sprache=en
- Copy link
-
BESSY II: High-resolution insights into individual biomolecules and catalysts
Very small biological samples and even individual biomolecules can now be examined under near-physiological conditions with high confidence at the BESSY II infrared beamline with a newly validated and improved technique: The nanoscale infrared spectroscopy (s-SNOM) with ultra-thin silicon-based membranes. An international team demonstrated after an initial proof of concept, that high-resolution (a few tens of nanometres) nano-IR measurements reliably match expected far-field IR spectra in an aqueous environment. This methodological advance provides a solid foundation for studying biomaterials or observing catalytic processes in a liquid environment.
-
Special prize by Jugend Forscht awarded to former school intern
Shaoxuan Wang has won a special prize in the Jugend Forscht competition for her project ‘Smart Capsules – intelligent microcapsules for glucose-dependent insulin release’. She designed the project as a “special achievement” for her A-levels. To carry out the experimental work, Shaoxuan was able to spend a further two weeks in the laboratory at the HZB Institute for Electrochemical Energy Storage, where she had completed a school internship two years earlier.
-
5000th protein structure at BESSY II: Starting point for a COVID drug
Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.